Mind Lab Pro Review: Who Paid for the Study Everyone Cites

Almost every review of this product leans on one clinical trial, and almost none of them mention who paid for it. That single omission is more important than any ingredient list, so this review is built around it: what a manufacturer-funded study is worth, what you can verify about this product without trusting anybody, and what we could not verify and have therefore left out.

What this review will and will not tell you

It will not recite a formula. Supplement panels change without announcement, this company's storefront blocks automated checking, and a milligram figure copied from a third-party summary and printed as fact is precisely the kind of confident error that makes supplement writing untrustworthy. If we cannot open the primary source, we do not restate its contents.

What it will do is give you the three things a review can honestly provide: a method for weighing the evidence that is cited for this product, a list of checks you can run on the current label in a couple of minutes, and a realistic account of what the first few weeks of a multi-ingredient cognitive supplement tend to feel like and why that feeling is a poor guide.

If you want the wider comparison against other pre-built products, our pre-built stack comparison applies the same rubric across the category rather than to one product.

The trials of the finished formula, read at source

There is a randomised, placebo-controlled university study that is routinely cited in reviews of this product, and two facts about it are repeated far more often than they are examined: it was conducted on the finished formula rather than on the individual ingredients, and it was funded by the manufacturer.

We could not open that primary publication at source on 6 September 2026, so we did not summarise it then. On 16 October 2026 we searched PubMed and found two placebo-controlled trials of the finished formula, both from the same University of Leeds group, and read them at source:

• Memory, 30 days (2023). 49 healthy adults aged 20–68 were pseudo-randomly assigned, 36 to Mind Lab Pro and 13 to placebo. The supplement group improved on every memory subtest of the Wechsler Memory Scale; the placebo group improved on two; the groups differed significantly on immediate and delayed recall (Abbott-Imboden et al., 2023, Human Psychopharmacology). The weak points are the allocation method and a placebo group a third the size of the treatment group.
• Decision-making, 60 days (2025). In a double-blind, placebo-controlled trial (allocation was pseudo-random, by order of recruitment) at two capsules a day for 60 days, accuracy and reaction time on a visual categorisation task did not improve; the authors instead reported changes in EEG network measures. The paper states that the funding was provided by Performance Lab Group, the maker (O'Reilly et al., 2025, Brain Sciences).

The 2025 paper also prints the formula it tested, per two-capsule serving, as taken from the manufacturer's site in November 2024: vitamin B6 2.5mg, folate (B9) 100mcg, vitamin B12 7.5mcg, citicoline 250mg, bacopa 150mg, organic lion's mane 500mg, phosphatidylserine 100mg, N-acetyl L-tyrosine 175mg, L-theanine 100mg, rhodiola 50mg and maritime pine bark extract 75mg. Labels change, so check the current one — but against single-ingredient trials, several of those amounts are low: bacopa at half the 300mg used in its 12-week trials (see our bacopa monograph), lion's mane at a sixth of the 3g in its one controlled trial, and rhodiola well below the 576mg used in its main placebo-controlled fatigue trial. Citicoline at 250mg matches the lower dose in the adolescent attention trial on our citicoline monograph.

This is not a criticism of the study, which may well be perfectly sound. It is a statement about what this page is entitled to assert. Our methodology sets out the same rule in general form, including what we do when a widely repeated figure turns out to have no traceable source.

How to weigh a manufacturer-funded study

Industry funding is not disqualifying. A great deal of legitimate nutrition research is funded by the industry it studies, for the straightforward reason that nobody else will pay to test a product. Treating "funded by the maker" as an automatic refutation is lazy, and it would delete much of the evidence base in this field.

What funding does is shift where you look. Read the pre-registration if one exists, and check whether the outcome reported is the outcome the researchers set out to measure. Check who held the data and who wrote the analysis. Check whether independent groups with no commercial relationship have replicated it. And check whether the study tested the formula you can buy, or an earlier version of it.

The strongest single question is the boring one: has anyone unconnected to the seller reproduced this? A funded trial with independent replication behind it is good evidence. A funded trial standing alone is a reason to be interested and not yet a reason to be convinced.

Apply that test to the ingredient-level literature too, not just to the finished-formula study. Several compounds commonly found in stacks of this type have research behind them that was conducted in older adults or in people with existing complaints, and that population choice usually carries more of the finding than any funding disclosure does. Our page on reading the lion's mane evidence works through that problem in detail on one ingredient.

What you can verify yourself, today

Open the current label and answer these. All five are checkable without trusting a review, including this one.

• Does every active ingredient carry its own stated amount, or do some sit inside a proprietary blend? American rules permit the gap: a panel must declare each ingredient "and except for dietary ingredients that are part of a proprietary blend, provide information on the amount of the dietary ingredient per serving" (FDA, Questions and Answers on Dietary Supplements, checked 6 September 2026).
• For each botanical, is the plant part, extract ratio and marker percentage given? A herb name on its own is not a specification.
• Is there an independent certificate of analysis you can actually open, tied to a batch? NCCIH notes that "A manufacturer's use of the term 'standardized' (or 'verified' or 'certified') does not necessarily guarantee product quality or consistency" (NCCIH, Using Dietary Supplements Wisely, checked 6 September 2026).
• Does anything in it duplicate something already in your cupboard? Multi-ingredient products are the easiest way to end up taking the same compound twice without noticing.
• Do the marketing claims stay at ingredient level, or do they promise an outcome in you? The second tells you about the company's judgement.

Open the current label and run those five checks. We hold an affiliate relationship with this brand, which is a fact you should weigh alongside everything above — see our disclosure.

What the first weeks actually feel like, and why that misleads

Stimulant-free multi-ingredient products share a predictable user experience, and understanding it prevents both premature abandonment and premature enthusiasm.

The early period usually feels like nothing. There is no acute cue — no lift, no edge, nothing that announces the capsule has been taken. People used to caffeine read that absence as failure, and a meaningful share stop before any cumulative ingredient could plausibly have done anything.

Later, many users report that things feel better. This is where the trap is, because by then several other things have also changed: the season, the workload, the sleep, and the well-documented tendency to notice evidence that justifies a purchase. Feeling better after four weeks is not evidence that the product caused it, and no amount of sincerity converts it into evidence.

The only fix is to have measured beforehand. Our tracking tutorial sets out a protocol with a baseline and a defined decision point, which is what makes a negative result possible. A trial that cannot fail is not a trial.

The honest cons

Attribution is the big one. A multi-ingredient formula is unattributable by construction: if it helps, you do not know which part helped, and you cannot drop the parts that did not. That is the price of convenience and it is rarely stated in reviews.

Cost per useful ingredient is the second. Breadth is expensive, and a broad formula usually means paying for several ingredients you did not want in order to get the two or three you did. Building the same two or three yourself is almost always cheaper, at the cost of your time — see building your own stack.

Third, the evidence for a finished blend does not simply inherit from its ingredients. Each ingredient's literature was generated at its own amount, in its own population, often alone. A blend is a new object, and the honest evidence question about it is a separate one.

The counter-argument

The best case for buying a product like this is one that sceptical reviews rarely make properly, so here it is. Most people will never assemble a stack from single ingredients. They will intend to, buy two of the four, lose interest, and take nothing. A single well-made product that they actually take every day beats an optimal protocol they abandon in a fortnight, and adherence is a real variable rather than a consolation prize.

The convenience argument also compounds with safety. One product with one label is easier to hand to a pharmacist than five bottles from four suppliers, and easier to stop cleanly if something goes wrong.

Where that argument stops is at price and at disclosure. Convenience is worth paying something for; it is not worth paying an unlimited premium for, and it does not justify a formula you cannot enumerate. If the label passes the five checks above, convenience is a legitimate thing to buy. If it does not, you are buying convenience and opacity together, and only one of those is useful.

Verdict, and what would change it

Our position is that this is a checkable product in a category with a lot of unchecked ones, that the two trials of the finished formula we could read come from one university group — one small with lopsided groups, the other maker-funded and negative on behaviour — and that, as far as we could establish on 16 October 2026, neither has been independently replicated, which supports interest rather than confidence. We would upgrade that on independent replication, on pre-registered outcomes, or on trials in healthy adults rather than in populations selected for having room to improve.

Before you buy anything in this category, work through our interactions checklist and then speak to a pharmacist, and read supplements and surgery if you have an operation scheduled. Our page on nootropic safety and side effects covers the ingredient-level risks.

Researched and drafted with AI assistance from published sources; edited and published by NorwegianSpark SA. We are independent supplement researchers, not clinicians. Formulas, prices and trial findings we could not open at source are deliberately absent rather than repeated from summaries. Last reviewed: October 2026.

Disclaimer: this article is for information only and is not medical advice. Dietary supplements are not assessed for safety and effectiveness before sale in the way that medicines are, and interactions with prescription medication are real. Nothing here is intended to diagnose, treat, cure or prevent any disease, and no dose is recommended. Talk to a doctor or pharmacist before starting anything, especially if you are pregnant, nursing, taking medication or under 18. Contains affiliate links — see our disclosure.